-
Make it like cafepharma, but for different industries. Learn more about CompanyUnderground
Proove Bioscience
- Thread starter Anonymous
- Start date
-
- Tags
- None
Brian might be a VP but it will be VP of prison duties somewhere. He is a very experienced con man who committed serious Fraud. His day is comming soon. Sorry Brian God can't save you, he may forgive you but you will pay the price in heaven and on earth.. I look forward to the day. Let's not forget joe, disgusting all around.
Brian would understand, call Rhonda or Joe, what do you have to lose.
Brian called me Friday and offered me a job at newco. I start in two weeks. Wish me luck !
Who ever you are that keeps posting Brian called, new co., new job, you have nothing better to do with your day than to write these posts. It's already out there what is going on with Brian and it's not a new co. Try doing some research. Your just bored. If it's Brian, you just can't come back after what you have done. Your a criminal, plain and simple. If it's Joe, is this how you spend your time waiting for that bang on the door. Find a short term hobby.
September 01, 2017
By Pat Anson, Editor
A controversial genetic testing firm under federal investigation for healthcare fraud has been placed into court-ordered receivership – a form of bankruptcy – that could lead to the restructuring and sale of the company. The CEO and founder of Proove Biosciences has also left the company.
In an interview with STAT, former CEO Brian Meshkin blamed the company's financial problems on “erroneous and damaging” reports that were based on “false allegations” by disgruntled former employees.
Proove Biosciences specializes in DNA testing that the company claims can improve the effectiveness of pain management treatment and determine whether a patient is at risk of opioid addiction.
In June, FBI agents raided the company’s headquarters in Irvine, California. Former and current employees who were interviewed by STAT said the agents were focused on possible kickbacks to doctors who encouraged patients to take Proove’s DNA tests. Physicians reportedly could make $144,000 a year in kickbacks that were called “research fees.”
In July, PNN reported that Proove was linked to a Medicare fraud case, in which three Indiana healthcare providers allegedly “caused Proove Bioscience… to falsely and fraudulently bill various health care programs for genetic tests... that were not medically necessary and never interpreted."
Proove was not named as a defendant in the Indiana case. In an email to PNN, Meshkin said Proove had cooperated with investigators.
“Proove has cooperated with both the FBI and US Attorney’s office on this case," said Meshkin. "With regards to tests being 'medically necessary', Proove received written and signed determinations of medical necessity supporting the tests ordered and billed to insurance carriers just like every other laboratory which requires such a determination on a test requisition form. Thus Proove operated appropriately and consistent with usual and customary practices."
Meshkin also defended Proove research, published in the Journal of Addiction Research & Therapy, which claimed to show the effectiveness of its genetic tests.The publisher of the journal, OMICS International, has been accused by the Federal Trade Commission (FTC) of deceiving researchers and readers about the true nature of its publications and peer review process.
"Proove can only speak to its experience with this particular journal,” Meshkin said in an email to PNN. "Specifically for papers submitted to this journal, our R&D team and academic collaborators engaged in documented, extensive peer-review, received suggested edits and provided responses to the suggested edits to the manuscripts submitted for review and publication. Thus, Proove would certainly consider the publications accepted from Proove-affiliated authors in that journal to be 'peer-reviewed'."
According to the FTC complaint filed last August, OMICS has created hundreds of "open access" online medical journals that publish articles with little or no peer review. Researchers are also charged significant fees to get their articles published by OMICS, a "pay to play" policy that some consider unethical because it diminishes the quality of academic journals and the peer review process.
Proove has aggressively promoted its genetic tests with healthcare providers around the country. A pain clinic in Montana, for example, had a Proove “patient engagement representative” employed on site at the Benefis Pain Management Center in Great Falls.
“We had a meeting one day and here are these people from Proove Biosciences. They told us they were doing a research project,” said Rodney Lutes, a physician assistant who was later fired by Benefis. “They wanted to come to Benefis, into the pain department, and test our patients. We were told this would be at no cost to the patient. My understanding was that they weren’t going to charge anybody, but I found out afterwards they were charging insurance companies.
“They said providers who participated in this would get some form of payment for participating in the program and for filling out all the paperwork.”
Lutes’ supervising physician at the clinic was Katrina Lewis, MD, a pain management specialist at Benefis who is listed as a member of Proove’s Medical Advisory Board. Lewis apparently plays a significant role at the clinic, even though she only works there part time. Benefis has denied that Lewis or any of its employees received kickbacks from Proove for referring business to them.
STAT reported that Proove’s restructuring was apparently ordered by Mike Leavitt, a Proove board member, who also served as Utah governor and secretary of the Department of Health and Human Services. Leavitt’s investment firm, Leavitt Equity Partners, provided about $7 million in funding to Proove, according to Meshkin.
A former Proove manager told STAT that she initially felt good about going to work for the company, but soon had misgivings about Proove's research and billing practices.
“It sucked the life out of me, on an integrity level,” said Rhonda Frantz-Smith. “It got more and more corrupt.”
- Pros
Enough negative anonymous reviews are telling of a company's culture and bottom line, despite what the CEO's Twitter may say. Let me also say that every positive review on here from December 23, 2016 on was the result of an instruction from supervisors to make the company look good. THERE ARE NO PROS IN WORKING FOR A COMPANY AS FRAUDULENT AS THIS. Proove Biosciences is a complete and utter joke, and everyone knows it, though many sweep it under the rug due to complacency, fear of repercussions, and the obvious need for a paycheck.
Besides receiving a paycheck, there are no pros in working for a giant scam. Although, this has been an eye-opening lesson into the level of fraud that plagues our healthcare system.Show Less
Cons
Everything about this place is a con (no pun intended). The testing is not real or proven. The paper that was published was a complete fabrication, and based only on other studies performed by Proove and its affiliates. Note: the CEO (who's background is in political science) is an author on every scientific "paper". Research 101: You can't exclude participants based on the inability to pay. You can, evidently, gouge their insurance companies for dates that patients weren't seen and make a fortune off of tests that aren't real, useful, or medically necessary. How do they make a fortune? By paying the doctors to get as many patients enrolled into their "study" as possible. If you think the payment isn't dependent on volume, you may want to brush up on the definition of "volume". Very few of the doctors performed the actual research-related services. Research assistants filled out the paperwork in order to pad the company's bottom line. Most docs thousands a month for doing next to nothing. They don't actually use the testing, because if they glanced at it for more than 5 minutes, they'd notice all of the discrepancies and errors.
Those are just the major issues, I could go on all day. The level of incompetence and ignorance from the corporate office is astounding and reflective of what's currently happening. Anytime anything was brought up about the illegal billing or bogus tests, that was either ignored or shut down right away. Patients would complain non-stop about it taking forever to receive their reports, their reports not being accurate, or the fact that we billed for dates of service when they weren't even in the country.
Also, sexual harassment is rampant
Advice to Management
There is no repairing this level of corruption. Those who made suggestions to do so were let go long ago. The proof's in the pudding - good luck, you're going to need it.